Presentation of First Time Attenders at Lymphedema Clinics

Lymphedema Clinical Trial

Official title: Presentation of First Time Attenders at Lymphedema Clinics: Cross-sectional Study

Status Completed

Clinical Trial Summary

The first aim of this research project is to identify what factors motivate patients to seek assessment for early lymphedema and further, to gain insight into the signs and symptoms of developing lymphedema and the concurrent physical measurements.

The second aim is to identify other sensory signs and symptoms and changes in body perception which may be perceived by the patient as reflective of lymphedema, and to identify to which degree they contribute to the patients' motivation to seek referral to lymphedema clinics.

Clinical Trial Description

One of the most challenging morbidities after breast cancer treatment is lymphedema. Approximately 20% of women treated for breast cancer with axillary lymph node dissection will be diagnosed with lymphedema. Pre- and post-operatively, women are informed about changes suggestive of lymphedema and guided about seeking further assessment. The investigators presume that if symptoms occur, patients will seek assessment. However, it is unknown whether this is true or if those prospectively monitored present earlier for treatment, or whether other factors specifically drive patients to seek further assessment. Understanding the early experience and presentation of secondary lymphedema will improve patient education and detection programs. ;

Related Conditions & MeSH terms

• Breast Neoplasm
• Breast Neoplasms
• Lymphedema

• NCT number: NCT03687749
• Study type: Observational
• Source: Universitaire Ziekenhuizen Leuven
• Status: Completed
• Start date: February 1, 2017
• Completion date: December 31, 2020